On Friday (4-12) the Food and Drug Administration approved an application by Advanced Technology Laboratories to use its ultrasound equipment to help determine if lumps in women’s breasts are cancerous. The screening could reduce the number of biopsies – over 700,000 annually – by almost 40 percent. ATL’s high-definition machines allow doctors to distinguish between benign and cancerous lumps. Long used to view developing fetuses, the procedure could spare hundreds of thousands of women the cost and ordeal of having a biopsy.
Uncategorized
